Twist Bioscience Corporation recorded an outflow of $89.0M in free cash flow in fiscal year 2026. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 10 fiscal years, from 2017 to 2026, and the quarters Twist Bioscience Corporation has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TWST Free Cash Flow by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TWST Free Cash Flow by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Twist Bioscience Corporation financials
Frequently Asked Questions
Twist Bioscience Corporation recorded an outflow of $89.0M in free cash flow in fiscal year 2026.
Twist Bioscience Corporation (TWST) reported an outflow of $75.6M in free cash flow in fiscal year 2025 and an outflow of $89.0M in free cash flow in fiscal year 2026. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 10 fiscal years this page covers, Twist Bioscience Corporation (TWST) free cash flow went from -$57.9M in fiscal year 2017 to -$89.0M in fiscal year 2026.
Twist Bioscience Corporation (TWST) reported -$20.1M in free cash flow in Q4 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Twist Bioscience Corporation (TWST) reported on that line in every period on record.